Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

31 results about "Renal cortex" patented technology

The renal cortex is the outer portion of the kidney between the renal capsule and the renal medulla. In the adult, it forms a continuous smooth outer zone with a number of projections (cortical columns) that extend down between the pyramids. It contains the renal corpuscles and the renal tubules except for parts of the loop of Henle which descend into the renal medulla. It also contains blood vessels and cortical collecting ducts.

Method for segmenting renal cortex images

InactiveCN102332164AAccurate segmentationInhibiting the problem of renal cortex embedded in the renal columnImage analysisRenal cortexDirected graph
The invention discloses a method for segmenting renal cortex images. The method comprises the following steps of: 1, performing initial segmentation on a kidney image by using a statistical shape model algorithm to acquire grid images of an initial outer surface S' of a kidney structure; 2, establishing sub-graphs G0 and G1 for the outer surface and the inner surface of a renal cortex respectively in a narrow band close to the grid images of the initial outer surface S' so as to obtain a weighted directed graph G=(G0, G1), designing cost functions C0 and C1 by aiming at the outer surface and the inner surface of the renal cortex respectively, generating an s-t graph Gst based on the weighted directed graph G=(G0, G1) and the cost functions C0 and C1, and extracting two layers of optimal surface images, namely an outer surface image S0 and an inner surface image S1 of the renal cortex, by using a max-flow minimal cut method; and 3, generating a data image Vcortex of a renal cortex body by using the outer surface image S0 and the inner surface image S1 of the renal cortex. By the method, the renal cortex structure can be segmented accurately, and the workload for manually segmenting the renal cortex is greatly reduced, so the method has important application values in the field of segmenting the renal cortex images and ventricular wall images with multi-surface structural characteristics.
Owner:INST OF AUTOMATION CHINESE ACAD OF SCI

Three-dimensional renal cortex positioning method based on three-dimensional active contour model and three-dimensional Harvard transformation

InactiveCN103679805AOvercome the disadvantage of only looking for location points but not providing more informationEffective positioningImage analysis3D modellingRenal cortexAbdominal cavity
The invention discloses a three-dimensional renal cortex positioning method based on a three-dimensional active contour model and three-dimensional Harvard transformation. The method includes the model establishing training part and the positioning part. The model establishing training part includes the steps that 10-20 sets of three-dimensional data are selected as training data; slices are selected through interpolation correction; marking points are drawn; a model is established through the three-dimensional active contour model, and the model is obtained and comprises an abdominal cavity outer contour, a renal cortex outer surface and a renal cortex inner surface; a kidney contour is stored in an R-table. The positioning part includes the step of searching positioning and the step of positioning the renal cortex; in the step of searching positioning, the kidney contour stored in the R-table is used for positioning the gravity center point of the whole kidney through the three-dimensional Harvard transformation; when the renal cortex is positioned, the model obtained through three-dimensional active contour model establishing is placed in the found gravity center of the kidney, and parameterization is performed and the range is regulated to be smaller so that searching can be performed on the gravity center point till the positioning result is obtained. With the method, the specific position of the renal cortex can be fast and effectively positioned.
Owner:SUZHOU UNIV

Three-dimensional perfusion type cell culture device and application thereof

The invention discloses a three-dimensional perfusion type cell culture device and an application thereof. The three-dimensional perfusion type cell culture device comprises a box body, a cover body and an elastic clamp, wherein a first circular groove is formed in the top surface of the box body, and a second circular groove with the same radius as the first circular groove is formed in the bottom surface of the cover body. In the cell culture device disclosed by the invention, vessels consisting of polyester fibers are arranged on the bottom surface of the groove, and a cell or tissue explant is positioned between two layers of vessels to form 'sandwich' culture; the vessels consisting of polyester fibers are used for replacing a scaffold material, so that the dead angle volume in cell culture is minimized to better conform to the in-vivo physiological microenvironment. A culture solution inlet channel and a culture solution outlet channel are formed on the side wall of the box body of the culture device respectively, and a culture solution flows into the groove cavity through the solution inlet channel and flows out through the solution outlet channel so as to realize perfusion culture. By adopting the device disclosed by the invention, the embryonic stem cell / progenitor cell at the new renal cortex part is successfully differentiated into renal tubule tissues.
Owner:康珞生物科技(武汉)有限公司

Folding electrode resectoscope

PendingCN107789053AMake up for the defect that it can only be cut back and forth in a straight lineReduce bleedingSurgical instruments for heatingRenal cortexRESECTOSCOPE
The invention discloses a folding electrode resectoscope. The resectoscope comprises an endoscope, an operating handle and an electric cutter, the endoscope comprises an endoscope rod, and the operating handle detachably sleeves the endoscope rod; the electric cutter comprises a cutting electrode and a supporting rod connected with the cutting electrode, the cutting electrode is arranged on the end portion of the supporting rod, an electrode steering structure enabling the end portion of the supporting rod to rotate along an arc path is arranged on the supporting rod, and the electrode steering structure comprises a node structure enabling the end portion to rotate around an axis and a traction structure connected with the end portion and the operating handle; through operation on the operating handle connected with the traction structure, the supporting rod can be driven to rotate in a folding mode, the cutting electrode can conduct cutting along the radian of a sac wall, the risks ofsac wall bleeding, damage to a renal cortex, fat liquefaction and the like are reduced, the defect that an existing electrode resectoscope can only linearly conduct cutting forward and backward is remedied, operation is easy and convenient, and the operation efficiency is improved while wounds are reduced.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

E-cadherin methylation detection method based on hydrosulphite sequencing method

The invention discloses an E-cadherin methylation detection method based on a hydrosulphite sequencing method. The E-cadherin methylation detection method includes the steps that firstly, rats which are 6-7 weeks old are selected, the kidneys of the killed rats are collected, connective tissue is sheared off, the renal cortex is taken and sheared into 50-100 mg tissue fragments, and the tissue fragments are quick-frozen with liquid nitrogen and stored in a -80 DEG C refrigerator; secondly, genome DNA is extracted with a genome DNA extraction reagent kit; thirdly, the concentration and purity of genome DNA are measured with a nucleic acid quantometer, the integrity of genome DNA is detected through 0.5%-1.0% sepharose gel electrophoresis, and DNA samples detected to be qualified are placed in a -20 DEG C--80 DEG C refrigerator for use; fourthly, genome DNA is modified with a methylation conversion reagent kit, and the concentration of modified genome DNA is determined with the nucleic acid quantometer; fifthly, PCR amplification is carried out under different experiment conditions; sixthly, samples used in follow-up steps are selected in the fifth step. By means of the E-cadherin methylation detection method, the success rate of E-cadherin methylation experiments is increased.
Owner:廖静

Application of 15-benzylidene-14-deoxy-11,12-dehydroandrographolide derivatives in anti-fibrosis drugs

ActiveCN109730990BDefine fibrotic activityIncreased fibrosisOrganic active ingredientsUrinary disorderRenal cortexDisease
The invention belongs to the technical field of medicine, and discloses the application of 15-benzylidene-14-deoxy-11,12-dehydroandrographolide derivatives in the preparation of drugs for preventing and treating human organ or tissue fibrosis. Experiments have proved that these compounds significantly inhibit TGF-β1-induced mesenchymal transition of human alveolar type II epithelial cells A549; significantly inhibit TGF-β1-induced mesenchymal transition of human renal cortical proximal tubule epithelial cells HK-2; inhibit Angiotensin Ⅱ (Ang Ⅱ)-induced proliferation of human primary cardiac fibrosis cells HCFB. Significantly reduce the degree of bleomycin-induced pulmonary fibrosis in mice, significantly reduce the degree of renal fibrosis in rats induced by unilateral ureteral ligation and the degree of myocardial fibrosis in Kunming mice induced by isoproterenol ISO. Using this type of compound as an active ingredient to prepare anti-fibrosis drugs such as kidney, lung, heart, etc., has high efficiency and low toxicity, and provides a new drug approach for the treatment and prevention of diseases related to fibrosis, thereby expanding the choice of clinical medication range, has a good prospect for application development.
Owner:ZHENGZHOU UNIV

Bio-dialysis therapy using JianShengBao to treat nephropathy uremia

InactiveCN107485669AEffective dialysis treatmentReduce toxic ingredientsOrganic active ingredientsUrinary disorderRenal cortexFermentation
Bio-dialysis therapy using JianShengBao to treat nephropathy uremia uses a preparation which is prepared from, by mass, 30 parts of Radix Astragali, 30 parts of mountain ginseng, 30 parts of wolfberry fruits, 20 parts of Salvia miltiorrhiza, 10 parts of rheum officinale, 20 parts of Herba Plantaginis, 20 parts of unprocessed rehmannia root, 10 parts of Dianthus superbus, 50 parts of balsam pear, 50 parts of watermelons, 50 parts of tomatoes, 50 parts of papaya, 50 parts of luffa, 50 parts of wax gourd, 100 parts of brown sugar and 1000 parts of purified water. Chinese herbal medicines, fruits and vegetables are fermented to effectively reduce toxic components in the microbial composite preparation, the dialysis therapy of patients is effectively realized only through oral administration without toxic or side effects; and the preparation obtained after the fermentation contains a large number of probiotics, biological enzymes and 16 kinds of amino acids, and can supplement nutrients to cells, kill harmful bacteria, promote cell metabolism, promote cell repairing and regeneration, purify blood, promote the repairing and the regeneration of renal cortex and renal medulla cells and promote the recovery of the filtering function and the secreting function of renal cells in order to treat the nephropathy uremia.
Owner:广州市圆强医药科技有限公司

Three-dimensional perfusion type cell culture device and application thereof

The invention discloses a three-dimensional perfusion type cell culture device and an application thereof. The three-dimensional perfusion type cell culture device comprises a box body, a cover body and an elastic clamp, wherein a first circular groove is formed in the top surface of the box body, and a second circular groove with the same radius as the first circular groove is formed in the bottom surface of the cover body. In the cell culture device disclosed by the invention, vessels consisting of polyester fibers are arranged on the bottom surface of the groove, and a cell or tissue explant is positioned between two layers of vessels to form 'sandwich' culture; the vessels consisting of polyester fibers are used for replacing a scaffold material, so that the dead angle volume in cell culture is minimized to better conform to the in-vivo physiological microenvironment. A culture solution inlet channel and a culture solution outlet channel are formed on the side wall of the box body of the culture device respectively, and a culture solution flows into the groove cavity through the solution inlet channel and flows out through the solution outlet channel so as to realize perfusion culture. By adopting the device disclosed by the invention, the embryonic stem cell / progenitor cell at the new renal cortex part is successfully differentiated into renal tubule tissues.
Owner:康珞生物科技(武汉)有限公司

Herba andrographitis lactone decalin structural modified derivative series I as well as preparation method and application thereof

PendingCN109734688ADefinitely Anti-Human OrgansClear activityOrganic chemistryDigestive systemRenal cortexDisease
The invention belongs to the technical field of medicines, and discloses an application of herba andrographitis lactone decalin derivatives in preparing drugs for preventing and treating various tissue and organ fibrosis of human bodies, and relates to herba andrographitis lactone decalin structural modified derivatives. The herba andrographitis lactone decalin structural modified derivative has astructure as shown in general formula I. Experiments show that the compounds can significantly inhibit the migrating activation of hepatic stellate cells, can significantly inhibit the mesenchymal transition of TGF-beta 1 induced human alveolar type-II epithelial cells A549, can significantly inhibit the mesenchymal transition of renal cortex proximal convoluted tubule epithelial cells HK-2, andcan significantly inhibit the migration of Angiotensin II (AngII) induced human heart myofibroblast HCFB. The compounds are used as active ingredients to prepare fibrosis-resisting drugs and are efficient and low in toxicity, and can provide a novel drug way for treating and preventing fibrosis related diseases, thereby enlarging the selection range of clinical medication, and having good application and development prospect. (Shown in the description).
Owner:ZHENGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products